
Please try another search
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Anthony Tennyson | - | 2020 | Co-founder, President, CEO & Director |
George Scorsis | 46 | 2020 | Co-founder & Chairman of the Board |
Stephen Page | - | 2021 | Independent Non Executive Director |
Kevin Fone | - | 2021 | Member of Pre-Clinical Advisory Board |
Barbara J. Mason | - | 2021 | Member of Clinical Advisory Board |
Shaun McNulty | - | 2021 | Member of Pre-Clinical Advisory Board |
Stephen Husbands | - | 2021 | Member of Pre-Clinical Advisory Board |
Harriet de Wit | - | 2021 | Member of Pre-Clinical Advisory Board |
David John Nutt | - | 2021 | Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer |
Ann Mithoefer | - | 2020 | Member of Clinical Advisory Board |
Paul Rutherford Carter | 63 | 2021 | Independent Director |
John Papastergiou | - | 2021 | Independent Non Executive Director |
Michael Mithoefer | - | - | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review